Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia - Herishanu, Yair; Avivi, Irit; Aharon, Anat; Shefer, Gabi; Levi, Shai; Bronstein, Yotam; Morales, Miguel; Ziv, Tomer; Shorer Arbel, Yamit; Scarfò, Lydia; Joffe, Erel; Perry, Chava; et al. (Blood, 2021)
Keywords: Aged; antibody response; BNT162 Vaccine; BNT162b2; Clinical Trials and Observations; CLL; CME; COVID-19; COVID-19 vaccine; COVID-19 Vaccines; Female; Free s; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - genetics; Leukemia, Lymphocytic, Chronic, B-Cell - therapy; Lymphoid Neoplasia; NEOPLASIA/Lymphoid leukemias; Plenary Papers; RNA, Messenger - genetics; SARS-CoV-2; NEOPLASIA/Lymphoid leukemias; COVID-19 vaccine; CLL; antibody response; BNT162b2